Every Cure: Unlocking Drug Potential With Artificial Intelligence — Waqas Haque and Tracey Sikora

In this installment of Oncology Data Advisor's Exploring Artificial Intelligence in Oncology series, Dr. Waqas Haque, Fellows Forum member and incoming Hematology/Oncology Fellow at the University of Chicago, speaks with Tracey Sikora, Co-Founder of Every Cure, a nonprofit organization whose mission is to repurpose existing FDA-approved drugs for other indications, especially in rare diseases.

Check out the discussion to learn more about:
• Challenges in finding treatments for rare diseases, including sparse data, low patient numbers, and lack of financial incentive for pharmaceutical companies
• Every Cure’s mission to unlock the potential of drugs that are already on the market
• Harnessing the latest AI and machine learning technology to structure data in a biomedical knowledge graph, looking at drugs, diseases, pathways, and targets
• Barriers in drug repurposing, including clinical validation and eventual approval
• The Advanced Research Projects Agency for Health (ARPA-H) grant and the importance of federal funding for rare disease research
• How to develop efficient clinical trials without a large sample size
• The future of AI-enabled drug discovery in oncology
• And more!